Introduction
D A great deal of interest has been attached to the study of metabolic functions in the rat brain. In many instances these metabolic data depend in part for their interpretation on knowledge of overall cerebral metabolic rate and of cerebral blood flow (CBF). Consequently, it is desirable to have methods for measurement of CBF in small animals. The usual modification of the Fick technique and of external detector washout method have made CBF measurement in the rat less than satisfactory, since there is considerable technical difficulty in serial sampling of blood from the sagittal sinus of small animals and because of the problems posed by the small size of the brain. Recently we established a method which modifies the Fick principle used by Kety, 1 Landau 2 and Reivich 3 utilizing 133 Xe to measure CBF in the rat, the details of which are described here.
Methods
The experiments were performed utilizing male Wistar rats weighing 250 to 350 gm. Anesthesia was induced with ether, and 5 mg per kilogram of body weight of tubocurarine Dr. Matsumoto is presently in the Department of Neurological Surgery, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama City, 700 Japan.
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chloride was injected intraperitoneally. Tracheostomy was performed immediately thereafter and an endotracheal tube was inserted to maintain artificial ventilation with 70% nitrous oxide and 30% oxygen. Rectal temperature was controlled at 37 °C with an electric lamp. The right femoral artery was cannulated with a PE-50 polyethylene tube (O.D. 0.038"), and a PE-10 polyethylene tube (O.D. 0.024") was cannulated through the right jugular vein into the superior vena cava as close as possible to the right atrium. The artery was used for continuous monitoring of arterial blood pressure and for anaerobic sampling of arterial blood. The vein was used for infusion of the radioactive tracer. A small coil (volume: 0.13 ml, total length: 52 cm) of PE-50 tubing was placed between the left femoral artery and the right femoral vein as an arteriovenous shunt. This was inserted into a well scintillation counter (Harshaw Type 12SW-12-W3, 3" diameter Nal crystal) and was used for continuously recording the concentration of the radioactive tracers in the arterial blood by a ratemeter (Nuclear-Chicago, Model 8732 Dual Channel Ratemeter) and recorder . The animal was fixed in the prone position on an operating stand to which a decapitator was attached. A midsagittal incision was made over the cranial vault and the skin was reflected. A small bottomless plastic cup was sutured in the wound over the cranial vault for eventual freezing ( fig.  1 ). The animals were maintained with Paco, values of 35 to 40 mm Hg, Pao, values of 95 to 130 mm Hg and blood pressure of over 100 mm Hg. After a steady state period of at least 20 minutes, Experimental arrangement for rat CBF. The picture illustrates the rat fixed in a headholder with the mechanical decapitator in place, the animal respirator to tracheal cannula, the microinfusion pump for l "Xe solution infusion, the arteriovenous shunt leading to a wellcounter, and the ratemeter-recording devices.
highest arterial IM Xe concentration as well as a linear change in concentration. Thirty seconds later, decapitation was performed. Simultaneously the head was frozen with liquid nitrogen to trap xenon in the brain tissue, since the temperature of liquid nitrogen ( -195.8°C ) is lower than the melting point of xenon (-11l.9°C). The brain was chiseled out in the frozen state, and divided into right and left hemispheres. Each hemisphere was put into a separate test tube and measured for radioactivity using the same wellcounter which was used for measuring the arterial concentration of xenon. After determining the weight of each hemisphere, hemispheric blood flow (HBF) was calculated according to the formula of Ci(T) = Xki J ?
T Ca-e-K " Tt) dt where Ci(T) is the concentration of xenon in the brain tissue at time T (30 seconds in these studies), X is the blood-brain partition coefficient for xenon, Ki is the rate of blood flow per unit weight of brain tissue multiplied by the reciprocal of the partition coefficient for that tissue, and Ca is the concentration of xenon in arterial blood. Flow was calculated from a hand integration of the arterial "'Xe time-concentration curve, using an ingenious simplification of computation devised by Goldman and Sapirstein. 5 For the curve integration, no correction was made for the smearing factor of the A-V shunt coil.
Since l u Xe of any given arterial concentration arrived in the brain and in the A-V shunt coil at a different time, this time difference was measured and the recorded arterial curve shifted accordingly. This correction varied from three to four seconds.
To determine the value of X, 12 rats were used and divided into two groups of six rats. Following the same procedure as outlined above, 1M Xe solution (20 to 50 iiC\ per milliliter) was infused intravenously at a constant speed of 0.2 ml per minute. In one group of animals after the arterial curve of xenon had reached a plateau maintained for one minute, and five or six minutes after xenon injection had begun, arterial blood was sampled and decapitation was performed. In the other group arterial blood sampling and decapitation were performed ten minutes after starting infusion of the xenon solution. The X value was calculated from the ratio of the radioactivity in a unit of brain tissue to a unit of blood. The size of a rat's brain is small and contains small relative amounts of white matter, and we did not separate gray matter and white matter in the hemispheres.
After a regular steady state period of 20 minutes, either hypocapnia or hypercapnia was induced. Hypocapnia was induced by increasing the tidal volume and Paco, was kept around 20 mm Hg. Hypercapnia was induced by adding CO, gas to the inspired gas and Paco, was adjusted to 60 mm Hg as nearly as possible. In both cases, the ventilation rate was kept constant. HBF determination was performed five minutes after the beginning of either hypocapnia or hypercapnia.
To assess the effect of pentobarbital anesthesia, the animals were tracheostomized, cannulated and fixed in the prone position on an operating stand under 70% nitrous oxide anesthesia. Pentobarbital (30 mg per kilogram) was then injected intraperitoneally. At the same time inspired gas was switched to 70% nitrogen instead of 70% nitrous oxide. Then the animals were kept at a steady state (and at Paco, of 35 to 40 mm Hg and Pao, of 95 to 130 mm Hg) for a period of 30 minutes until HBF determinations were performed.
Results
The values of A, which were determined from the rat hemispheres, are shown in table 1. These values are very close to unity which is often assumed to be the A value. We utilized unity as the value of X to simplify the calculation of HBF.
The results of the HBF in the rat in various conditions are as shown in tables 2 and 3. In normocapnia under 70% nitrous oxide anesthesia HBF was 86 ± 15 ml/100 gm per minute (mean ± SD); with hypocapnia the Paco, was about 20 mm Hg and HBF was 40 ± 5 ml/100 gm per minute; with hypercapnia the Paco, was 63 mm Hg and HBF was 187 ± 10 ml/100 gm per minute. With pentobarbital anesthesia the Paco, was 38 mm Hg and HBF was 41 ± 8 ml/100 gm per minute.
Discussion
A great variety of methods for determining CBF have been developed since Kety and Schmidt" established the nitrous oxide method. External detection and the use of radionuclide tracers allow not only CBF of the whole brain, but also regional CBF to be determined in both man and the experimental animal. Every method has some disadvantage, and there is as yet no perfect method for all purposes. There are technical difficulties especially in determining CBF in small animals like the rat. Nevertheless, several investigators have already reported CBF values in the rat brain utilizing different methods (table 4) .
The particular importance of adapting CBF determinations to the rat as an experimental animal 
depends upon the frequency with which this animal has served as a model for a variety of neurochemical, physiological and pathological changes in the brain. In many experimental states a knowledge of the effects of a given manipulation of the model on the CBF would be valuable or even critical to know. Not only the small size of the animal but the peculiarities of its brain arterial supply and venous drainage as well as the location of the brain in the cranium pose serious difficulties in translating methods useful in other animals to rats or smaller animals. Moreover, there are many experimental states in which the assumptions of the Kety-Schmidt technique (and its radionuclide-related techniques) cannot be made. As examples, local or regional brain disease may violate the assumption of homogeneous perfusion, and changing physiological states associated with an acute stress may violate the requirement of a steady state in regard to several variables.
One method may be perfectly suitable for one kind of experiment, while completely invalid for another. One of the most difficult and most important of the requirements is that of the steady state, and a method demanding relatively short time intervals during which a steady state must be produced (particularly in regard to blood pressure, Pao,, Paco,, intracranial pressure, and distribution of cerebral edema or ischemia) would have great utility.
Regional clearance of hydrogen, measured at the tip of a hydrogen electrode, allows quantitative estimates of CBF at the electrode tip.
7 This does not allow estimates of larger regions as of average hemispheric flow. Utilization of thermocouples 8 or thermistors allows monitoring of directional changes, but cannot be readily calibrated to derive quantitative flow and, like the hydrogen electrode, may produce local tissue damage on insertion. Aukland 9 studied the effect of electrode damage and concluded it to be minimal, and Haining et al. 7 agreed in a study of the rat brain. Our own experience with fine thermistor probes indicates that although gross damage to the tissue by the probe is readily recognized by the poor response characteristics in the measurements, minimal injury is not unusual and must be a factor in disturbing the local physiological state of the tissue, not only potentially altering flow characteristics but, more importantly, disturbing the biochemical state of the regional tissue.
Radionuclide-labeled microspheres 10 pose a problem in achieving and maintaining uniform suspension during injection and also require simultaneous measurement of the cardiac output. These limitations may be serious in studies assessing changing experimental conditions or in which biochemical measurements are to be compared. A similar objection may be raised to the indicatorfractionation technique of Goldman and Sapirstein ethanol was used as a tracer, and decapitation was done 30 seconds after starting the radioisotopic injection in the rat. The Kety-Schmidt method is preferred, since one can get the value of the cerebral metabolic rate of oxygen utilization (CMR0 2 ) and that of CBF at the same time, and there are fewer hypothetical assumptions in the formula for the CBF calculation than in other methods. But in the Kety-Schmidt method as modified by Eklof and Siesjo, blood transfusion was necessary to prevent blood pressure problem of surprising magnitude because of the need to relate the timing of the samples to the brain-arrival time of blood of comparable concentration. Since they showed that a second source of error related to assumptions of homogeneous perfusion requires utilization of short infusion times (recommended 30 seconds), such sampling time errors add to the difficulty of the method. Use of 133 Xe allows direct measurement of the blood concentration in an artificial A-V shunt, by virtue of the y activity of the radionuclide, and the time error between shunt and brain can be directly assessed by external detection of radionuclide peak between shunt and brain.
Gjedde et al. 17 ' 18 have recently improved the method of Eklof by cannulation of the rat jugular bulb and this application of the Kety-Schmidt technique, using integrated blood samples, appears to be the most satisfactory method for experimental states in which a uniform, stable alteration in CBF may be assessed for the whole brain. It must be observed that the assumption that the lateral sinus-jugular bulb blood of the rat is representative of mixed cerebral venous total outflow has never been established for the rat, nor for any animal other than monkey or man, and in those species only incompletely. This assumption is essential for estimation of CBF by the KetySchmidt technique and is probably true for the rat based on indirect evidence (e.g., derived flow values vary appropriately with changes in Paco 2 ).
Since there are no published values for the partition coefficient (X) determined in the rat brain for 133 Xe, we evaluated this in a way suitable for the particular application we had in mind for this method. That is, our biochemical determinations were mean values for particular gross segments of whole brain representing indeterminate mixtures of gray and white matter, and it is for such whole brain mixtures of comparable kind that we wish to derive flow values. Similarly, our arterial 133 Xe concentration was achieved by slow ramp intravenous injection of 133 Xe saline solutions which resulted in a very much more rapid arterial plateau than that achieved by breathing a fixed concentration of gaseous 133 Xe. In our determination of X, arterial plateau occurred prior to five minutes in all animals, judged by the continuously recorded A-V shunt coil values. In the second group of animals, the infusion time was doubled to ten minutes, and the derived values shown in table 1 indicate essentially identical results. Hemoglobin values in these animals varied from 14 to 17 gm % and in this range the variation in X related to hemoglobin differences is slight and can be disregarded, although variations beyond these concentrations should not be ignored. 19 In the application that we have for this method, animals with hemoglobin outside these ranges would not be appropriate, but should one study, for example, hypovolemic hypotension produced by phlebotomy, different X values would need to be determined for measurements made on extremes of hemoglobin concentrations.
For purposes of validation of any method of cerebral circulation, no ideal reference standard exists, a problem which has always bedeviled investigators interested in the cerebral circulation. Direct methods, such as the bubble-flowmeter, are not adaptable to the vascular tree of lower order mammals, for example. The next best approach is to use the best validated method used by others. For the rat as well as for most species, this is a Kety-Schmidt method, and yet application of this approach is still in a developmental stage methodologically for the rat (as has been already noted). A third approach is to use a physiological stimulus whose quantitative effect has been found to be relatively predictable and reproducible in many species and test a new method's ability to assess expected changes from that stimulus. It is this approach that has been chosen here. In using a Paco, change to produce changes in CBF, it seemed reasonable to choose values that lie at the extremes of variations that might occur under physiological stress, and not employ extremes which result in indeterminate secondary effects or which are beyond those attainable by usual physiological situations. For Paco, this range probably extends from 15 to 20 mm Hg to 60 to 70 mm Hg. This range includes the "straightline" portion of the curves published by many investigators for CBF versus Paco, relationships in a variety of animals.
"
22 To choose greater extremes would be expected to lead to incorrect assumptions regarding the slope of that response curve inside narrower limits of variation, since it is well known that the slope of the curve changes beyond the extremes of 15 mm Hg to 70 mm Hg at both the high and the low range. As noted in table 4, the summarized results of others are in most instances derived from values of Paco, beyond these limits at one end or the other of the range.
The presently described method is applicable to measurements in any desired region of the brain which can be physically separated by dissection in the ultracold (liquid nitrogen temperature) brain. This includes separation of hemispheres and of brain stem. It also includes separation of parts of the brain that can be achieved by scraping into smaller fractions, so that a sample of one or another portion of the cortex may be taken. Because of the brittle nature of the brain at -196°C, sharp dissection of central nuclei, for example, is difficult or impossible. The use of xenon as the tracer imposes the requirement of maintaining the very cold state until the brain material can be counted for radioactivity. Kety-Schmidt methods that are dependent on venous outflow tracer curves are useless in experimental states in which regional flow changes are known to be present.
A further utility of this method is that it is much less dependent on steady-state assumptions than the Stroke, Vol. 6, November-December 7975 Kety-Schmidt method. Not only is the time during which constancy of cerebral perfusion must be assumed much shorter (30 seconds), but the effect of changes of Paco,, pressure, shifting intracranial pressure, etc., is less since in this method the variable that most requires being "steady" is only the arterial perfusion of the brain area to be studied, and is not dependent on shifts in venous drainage which are known to occur readily in jugular vein blood under a variety of otherwise unimportant stresses that may occur in experimental models.
Prior application of methods similar to the present one has involved methods other than decapitation to kill the animal at the conclusion of the tracer infusion time -usually an intravenous bolus of KC1. If one follows the intra-arterial pressure curve at such a time, pressure falls to zero over 20 or more seconds, although ECG evidence of rhythmic heart beat may disappear in three to five seconds. Uncertainty as to the nature of some continuing arterial perfusion of the brain over time intervals of more than one or two seconds (out of a total of 30 seconds) introduces a variable of unacceptable magnitude in the calculation and, since it is indeterminate, not correctable. In this and similar methods we consider decapitation with precisely determined timing the only acceptable method.
The selection of a 30-second infusion time was first made on empiric grounds. This relates to the use of an intravenous ramp injection of radionuclide. The rate of infusion is limited by volume considerations, and the time of arterial equilibrium is fixed by rate of infusion and rate of blood to alveolar outflow. In our application the arterial curve rises steeply and fairly linearly for 30 to 40 seconds and then begins an asymptotic relationship to a plateau of final arterial concentration which, as noted, was usually achieved between three and four minutes. The nature of the method is such that large increments of arterial activity in successive increments of time are desirable, and this was best achieved in the first 30 seconds. Eklof 16 has completely described additional theoretical reasons why a 30-second time interval is preferable and more accurate than longer time intervals.
The use of an A-V shunt for recording the arterial 133 Xe concentration avoids the difficulties of serial blood sampling under rigorous closed system requirements and with attendant problems in syringe and system dead space correction.
For study of circumstances in which a uniform alteration of CBF can be assessed, this method does not allow derivation of a value for CMRO 2 . Such a determination would not be especially meaningful, of course, in experimental states with known regional alterations in brain flow, but might be very useful in other situations. To obtain this value for use with the present method, a sample of sagittal sinus or jugular blood and an arterial sample would need to be separately taken, presumably before or during the final 30 seconds of flow determination, for analysis of oxygen content and determination of arteriovenous oxygen difference.
The determination of biochemical changes in the brain used for regional flow assessment is readily carried out after brain radioactivity counting with one single limitation, that is, that transcalvarial freezing of the sample can begin only at the instant of decapitation. Certain kinds of biochemical alterations, especially in parts of the brain deeper than 3 to 4 mm from the surface, may occur before freezing arrests these postmortem artifacts. 23 ' 24 Nonetheless biochemical, neurotransmitter, neurophysiological and related determinations can be assessed along with regional blood flow in precisely the same anatomical location, in the same animal and under the identical experimental conditions utilizing this method. No other published method applicable to the rat, of which we have knowledge, has this capability.
Summary
A method of quantitatively assessing cerebral blood flow in the rat is described utilizing 133 Xe infused as a solution intravenously. After 30 seconds of 133 Xe infusion the animal is decapitated and the brain frozen by exposure of the dissected calvarium to liquid nitrogen, followed by freezing of the whole head. The actual time-concentration change in arterial blood is directly measured by passing an external arteriovenous shunt through a gamma well-counter. CBF is measured in any or all desired parts of the brain dissected in the cold state, and flow calculated according to a formula derived by Kety. The method is shown to produce values of CBF that vary quantitatively in the expected fashion for changes of Paco, and in states of nitrous oxide and pentobarbital anesthesia, as well as being closely comparable in magnitude to values obtained by others utilizing standard Kety-Schmidt methods.
The method has the important advantage of being accomplished in a short time interval of 30 seconds (allowing short-time steady-state requirements), of assessing either regional, hemispheric or whole brain flow, and of allowing measurement of any other metabolic, biochemical or pharmacological variable in the very same tissue, subject only to limitations which are discussed. It is adaptable to other radionuclide tracers with modifications. The calculations can be derived easily without resorting to a computer, and the method employs equipment likely to be readily available in a laboratory where y radionuclides are used, without major alterations in equipment.
